Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Alanyl-glutamine Supplementation of Standard Treatment for C. Difficile Infection: a Randomized, Double-blind, Placebo-controlled Trial

NCT04305769 is registered in ClinicalTrials.gov with University of Virginia as lead sponsor.

NCT NCT04305769
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04305769 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Alanyl-glutamine Supplementation of Standard Treatment for C. Difficile Infection: a Randomized, Double-blind, Placebo-controlled Trial
Lead sponsor
University of Virginia
Phase
Phase 2
Overall status
Recruiting
Start date
June 1, 2021
Completion date
June 30, 2027
Enrollment
260 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

clostridia difficile colitis, clostridioides difficile infection, clostridium difficile diarrhea, clostridium difficile infection